Scientists discover that loss of MTAP gene disables immune defenses in tumors; DFMO drug could reactivate STING pathway.
Tecentriq reduced the risk of death by 41% and the risk of disease recurrence or death by 36% compared with placebo 1 IMvigor011 is the first global phase III study to read out pioneering a ctDNA- ...
A group of chemists, microbiologists, and ecologists has developed a molecular probe (a molecule designed to detect e.g. proteins or DNA inside an ...
Your genetic information could be used to create a class of super soldiers, or even super geniuses, in China. Even scarier: ...
A major collaboration between UC San Diego and 23andMe identified genes that shape cannabis use behaviors. The study linked the CADM2 and GRM3 genes to cannabis use and connected these patterns to ...
2h
Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the ...
New research reveals how complex interactions between genetic variants can explain different outcomes in disorders like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback